Skip to main content
logo
Assembly Biosciences logo
Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
23.53
+0.71 (3.11%)
Oct 9, 2026, 4:00 PM EDT - Market closed

Assembly Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
74.8572.328.527.16-6.25
Revenue Growth
125.12%153.52%298.16%---92.09%
Gross Profit
11.197.49-27.41-41.74-69.08-63.9
Operating Income
-8.8-12.12-45.42-64.65-93.01-92.4
Net Income
-0.04-6.12-40.18-61.23-93.09-129.86
Earnings Per Share
-0.00-0.55-6.69-13.38-23.08-36.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
320.36248.11112.08130.2591.61174.6
Total Debt
2.352.633.092.343.476.48
Net Cash (Debt)
318.01245.48108.99127.9188.15168.12
Net Cash Growth
341.09%125.23%-14.79%45.11%-47.57%-18.50%
Net Cash Per Share
19.4421.9018.1527.9421.8546.61

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-38.48-41.09-51.1222.74-84.46-93.4
Capital Expenditures
-0.09-0.07-0.03-0.26-0.1-3.1
Free Cash Flow
-38.57-41.16-51.1522.49-84.57-96.49
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
14.95%10.36%-96.12%---
Operating Margin
-11.76%-16.76%-159.26%-902.50%--1477.42%
Pretax Margin
-0.06%-8.47%-139.72%-854.32%--2116.82%
Profit Margin
-0.06%-8.47%-140.87%-854.78%--2076.35%
FCF Margin
-51.53%-56.93%-179.33%313.95%--1542.88%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
---2.40--
PS Ratio
6.407.443.527.53-17.83